Fortis Healthcare Secures NCLT Approval for Subsidiary Merger Scheme

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Fortis Healthcare has secured final NCLT approvals from New Delhi and Chandigarh for its composite merger scheme involving four wholly-owned subsidiaries. The restructuring merges Fortis Emergency Services, Fortis Cancer Care, Fortis Health Management (East), and Birdie & Birdie Realtors into Fortis Hospitals Limited, with an appointed date of April 1, 2022. The scheme aims to rationalize operations and reduce administrative overhead without affecting the listed entity's shareholding pattern.

powered bylight_fuzz_icon
15514686

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare Limited , a leading player in the Indian healthcare sector, has received final approval from the National Company Law Tribunals (NCLTs) for its composite scheme of merger by absorption involving multiple wholly-owned subsidiaries.

NCLT Approval Timeline

The company has secured approvals from both jurisdictional NCLTs for the restructuring scheme:

Approval Authority: Date
NCLT New Delhi: January 5, 2026
NCLT Chandigarh: January 16, 2026
Appointed Date: April 1, 2022
Order Receipt: January 15, 2026 at 7:20 PM

Entities Involved in the Merger

The scheme involves the merger of four wholly-owned subsidiaries into Fortis Hospitals Limited (FHsL):

Transferor Companies: Business Area
Fortis Emergency Services Limited (FESL): Healthcare services
Fortis Cancer Care Limited (FCCL): Healthcare services
Fortis Health Management (East) Limited (FHML): Healthcare services
Birdie & Birdie Realtors Private Limited (B&B): Renting and maintenance of immovable property

Financial Details of Subsidiaries

The financial profile of the entities involved in the merger shows varying scales of operations:

Entity: Paid-up Capital (₹ Million) Turnover (₹ Million)
FESL: 0.50 -
FCCL: 0.50 -
FHML: 0.50 -
B&B: 0.10 -
FHsL: 799.88 12,824.21

Strategic Rationale and Implementation

The merger aims to achieve operational rationalization and cost optimization through simplified management structures and streamlined financial reporting. The scheme will become effective once certified copies of both NCLT orders are filed with the jurisdictional Registrar of Companies.

Since all transferor companies are wholly-owned subsidiaries of FHsL, the merger will not involve any share issuance or cash consideration. The shareholding pattern of Fortis Healthcare Limited, the listed entity, will remain unchanged following this internal restructuring.

Regulatory Compliance

The transaction falls under related party arrangements but is exempt from Section 188 requirements of the Companies Act, 2013, as per MCA General Circular No. 30/2014. Additionally, related party transaction provisions under SEBI LODR Regulations do not apply to this scheme under Regulation 23(5)(c).

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.50%-4.22%-15.94%-12.23%-30.99%+171.91%

More News on Fortis Healthcare

1 Year Returns:-30.99%